[Treatment of patients with trichocephaliasis with decreasing doses of ditiazanine and naphthamon].
D000328:Adult; D000650:Amnion; D000871:Anthelmintics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001598:Bephenium Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002478:Cells, Cultured / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D003967:Diarrhea / Q000139:chemically induced; D004341:Drug Evaluation; D004622:Embryo, Mammalian; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D009325:Nausea / Q000139:chemically induced; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014257:Trichuriasis / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D000871:Anthelmintics; D001598:Bephenium Compounds; D013844:Thiazoles
K voprosu o lechenii bol'nykh trikhotsefalezom snizhennymi dozami ditiazanina i naftamona